For instance, the oncogenic RBP Musashi 2 (MSI2) was shown to be highly expressed in hepatocellular carcinoma, and was associated with cancer stem cell stemness and chemoresistance through the activation of LIN28A, another RBP (Fang et al., 2017). Here, MSI2 is linked to hepatocellular carcinoma.